Published in
Elsevier, Multiple Sclerosis and Related Disorders, (12), p. 82-87, 2017
DOI: 10.1016/j.msard.2017.01.009
Links
Tools
Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab
Journal article published in 2017 by
Jan Fagius,
Amalia Feresiadou,
Elna-Marie Larsson,
Joachim Burman 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 